https://www.danafarberplga.org/publications/174/2020-04-22T19:04:03+00:00https://www.danafarberplga.org/publications/ambient-mass-spectrometry-for-the-intraoperative-molecular-diagnosis-of-human-brain-tumors/2020-04-22T18:58:45+00:00https://www.danafarberplga.org/publications/characterization-of-torin2-an-atp-competitive-inhibitor-of-mtor-atm-and-atr/2020-04-22T18:59:34+00:00https://www.danafarberplga.org/publications/systematic-identification-of-genomic-markers-of-drug-sensitivity-in-cancer-cells/2020-04-22T18:57:14+00:00https://www.danafarberplga.org/publications/efficacy-of-intermittent-combined-raf-and-mek-inhibition-in-a-patient-with-concurrent-braf-and-nras-mutant-malignancies/2020-04-22T19:09:36+00:00https://www.danafarberplga.org/publications/relief-of-profound-feedback-inhibition-of-mitogenic-signaling-by-raf-inhibitors-attenuates-their-activity-in-brafv600e-melanomas/2020-04-22T18:58:14+00:00https://www.danafarberplga.org/publications/the-central-nervous-system-restricted-transcription-factor-olig2-opposes-p53-responses-to-genotoxic-damage-in-neural-progenitors-and-malignant-glioma/2020-04-22T18:55:58+00:00https://www.danafarberplga.org/publications/phosphorylation-state-of-olig2-regulates-proliferation-of-neural-progenitors/2020-04-22T18:56:31+00:00https://www.danafarberplga.org/publications/182/2020-04-22T19:05:36+00:00https://www.danafarberplga.org/publications/genomic-analysis-of-diffuse-pediatric-low-grade-gliomas-identifies-recurrent-oncogenic-truncating-rearrangements-in-the-transcription-factor-mybl1/2020-04-22T19:00:03+00:00https://www.danafarberplga.org/publications/recurrent-somatic-alterations-of-fgfr1-and-ntrk2-in-pilocytic-astrocytoma/2020-04-22T19:03:38+00:00https://www.danafarberplga.org/publications/pdgfra-amplification-is-common-in-pediatric-and-adult-high-grade-astrocytomas-and-identifies-a-poor-prognostic-group-in-idh1-mutant-glioblastoma/2020-04-22T19:04:51+00:00https://www.danafarberplga.org/publications/absence-of-oncogenic-canonical-pathway-mutations-in-aggressive-pediatric-rhabdoid-tumors/2020-04-22T18:57:38+00:00https://www.danafarberplga.org/publications/tight-coordination-of-protein-translation-and-hsf1-activation-supports-the-anabolic-malignant-state/2020-04-22T19:01:01+00:00https://www.danafarberplga.org/publications/chaperones-as-thermodynamic-sensors-of-drug-target-interactions-reveal-kinase-inhibitor-specificities-in-living-cells/2020-04-22T19:01:37+00:00https://www.danafarberplga.org/publications/separated-at-birth-the-functional-and-molecular-divergence-of-olig1-and-olig2/2020-04-22T19:46:00+00:00https://www.danafarberplga.org/publications/pediatric-low-grade-gliomas-how-modern-biology-reshapes-the-clinical-field/2020-04-22T19:09:59+00:00https://www.danafarberplga.org/publications/261/2020-04-22T19:44:22+00:00https://www.danafarberplga.org/publications/distinct-bimbh3-bimsahb-stapled-peptides-for-structural-and-cellular-studies/2020-04-22T19:11:16+00:00https://www.danafarberplga.org/publications/targeted-disruption-of-the-bcl9%ce%b2-catenin-complex-inhibits-oncogenic-wnt-signaling/2020-04-22T19:11:43+00:00https://www.danafarberplga.org/publications/long-term-outcome-of-4040-children-diagnosed-with-pediatric-low-grade-gliomas-an-analysis-of-the-surveillance-epidemiology-and-end-results-seer-database/2020-04-22T19:12:31+00:00https://www.danafarberplga.org/publications/276/2020-04-22T19:13:26+00:00https://www.danafarberplga.org/publications/intraoperative-mass-spectrometry-mapping-of-an-onco-metabolite-to-guide-brain-tumor-surgery/2020-04-22T19:13:41+00:00https://www.danafarberplga.org/publications/phase-2-randomized-flexible-crossover-double-blinded-placebo-controlled-trial-of-the-farnesyltransferase-inhibitor-tipifarnib-in-children-and-young-adults-with-neurofibromatosis-type-1-and-progress/2020-04-22T19:14:16+00:00https://www.danafarberplga.org/publications/recurrent-somatic-alterations-of-fgfr1-and-ntrk2-in-pilocytic-astrocytoma-2/2020-04-22T19:45:18+00:00https://www.danafarberplga.org/publications/433/2020-04-22T19:39:07+00:00https://www.danafarberplga.org/publications/development-of-covalent-inhibitors-that-can-overcome-resistance-to-first-generation-fgfr-kinase-inhibitors/2020-04-22T19:41:02+00:00https://www.danafarberplga.org/publications/time-to-rethink-the-unthinkable-upfront-biopsy-of-children-with-newly-diagnosed-diffuse-intrinsic-pontine-glioma-dipg/2020-04-22T19:54:40+00:00https://www.danafarberplga.org/publications/successful-treatment-of-a-progressive-braf-v600e-mutated-anaplastic-pleomorphic-xanthoastrocytoma-with-vemurafenib-monotherapy/2020-04-22T19:42:11+00:00https://www.danafarberplga.org/publications/recurrence-after-gross-total-resection-of-low-grade-pediatric-brain-tumors-the-frequency-and-timing-of-postoperative-imaging/2020-04-22T19:53:57+00:00https://www.danafarberplga.org/publications/targeting-braf-in-pediatric-brain-tumors/2020-04-22T19:41:33+00:00https://www.danafarberplga.org/publications/diffuse-intrinsic-pontine-glioma-a-reassessment/2020-04-22T19:43:08+00:00https://www.danafarberplga.org/publications/exome-sequencing-identifies-braf-mutations-in-papillary-craniopharyngiomas/2020-04-22T19:41:17+00:00https://www.danafarberplga.org/publications/genome-sequencing-of-shh-medulloblastoma-predicts-genotype-related-response-to-smoothened-inhibition/2020-04-22T19:42:43+00:00https://www.danafarberplga.org/publications/phase-ii-trial-of-pirfenidone-in-children-and-young-adults-with-neurofibromatosis-type-1-and-progressive-plexiform-neurofibromas/2020-04-22T19:42:29+00:00https://www.danafarberplga.org/publications/a-brain-penetrant-raf-dimer-antagonist-for-the-noncanonical-braf-oncoprotein-of-pediatric-low-grade-astrocytomas/2020-04-22T19:23:58+00:00https://www.danafarberplga.org/publications/a-chemoproteomic-approach-to-query-the-degradable-kinome-using-a-multi-kinase-degrader/2020-04-22T19:20:37+00:00https://www.danafarberplga.org/publications/a-landscape-of-pharmacogenomic-interactions-in-cancer/2020-04-22T19:25:13+00:00https://www.danafarberplga.org/publications/myb-qki-rearrangements-in-angiocentric-glioma-drive-tumorigenicity-through-a-tripartite-mechanism/2020-04-22T19:25:38+00:00https://www.danafarberplga.org/publications/brainstem-angiocentric-gliomas-with-myb-qki-rearrangements/2020-04-22T19:37:43+00:00https://www.danafarberplga.org/publications/rapid-discrimination-of-pediatric-brain-tumors-by-mass-spectrometry-imaging/2020-04-22T19:17:56+00:00https://www.danafarberplga.org/publications/immunophenotyping-of-pediatric-brain-tumors-correlating-immune-infiltrate-with-histology-mutational-load-and-survival-and-assessing-clonal-t-cell-response/2020-04-22T19:18:29+00:00https://www.danafarberplga.org/publications/management-of-pediatric-low-grade-glioma/2020-04-22T19:16:59+00:00https://www.danafarberplga.org/publications/old-meet-new-the-path-to-combination-treatments-in-pediatric-low-grade-gliomas/2020-04-22T19:16:37+00:00https://www.danafarberplga.org/publications/mitogenic-and-progenitor-gene-programs-in-single-pilocytic-astrocytoma-cells/2020-04-22T19:16:21+00:00https://www.danafarberplga.org/publications/1113/2020-06-16T19:33:04+00:00https://www.danafarberplga.org/publications/the-power-of-human-cancer-genetics-as-revealed-by-low-grade-gliomas/2020-06-16T19:21:27+00:00https://www.danafarberplga.org/publications/molecular-profiling-and-targeted-therapy-in-pediatric-gliomas-review-and-consensus-recommendations/2020-06-16T19:31:01+00:00